16:16 EST Lexaria Bioscience files to sell 1.62M shares of common stock for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on LEXX:
- Lexaria announces additional results from human pilot study of DehydraTECH
- Lexaria Bioscience expands studies of proprietary platform
- Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating Proprietary Drug-Delivery Platform for Improved Efficacy of GLP-1 Drugs
- Lexaria Bioscience enters license agreement with SulfoSyn
- Lexaria Bioscience granted two Canadian patents